BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30938983)

  • 1. Extradomain-B Fibronectin-Targeted Dextran-Based Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Probe for Detecting Pancreatic Cancer.
    Han Z; Zhang S; Fujiwara K; Zhang J; Li Y; Liu J; van Zijl PCM; Lu ZR; Zheng L; Liu G
    Bioconjug Chem; 2019 May; 30(5):1425-1433. PubMed ID: 30938983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis.
    Qiao PL; Gargesha M; Liu Y; Laney VEA; Hall RC; Vaidya AM; Gilmore H; Gawelek K; Scott BB; Roy D; Wilson DL; Lu ZR
    Magn Reson Imaging; 2022 Feb; 86():37-45. PubMed ID: 34801672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Exchange Saturation Transfer for Pancreatic Ductal Adenocarcinoma Evaluation.
    Wang L; Zhou Z; Gaddam S; Wang N; Xie Y; Deng Z; Fan Z; Christodoulou AG; Han F; Lo SK; Wachsman AM; Hendifar AE; Jiang T; Pandol SJ; Li D
    Pancreas; 2022 May; 51(5):463-468. PubMed ID: 35858211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Assessment of the Effectiveness of Magnetic Resonance Molecular Imaging of Extradomain-B Fibronectin for Detection and Characterization of Oral Cancer.
    Hall RC; Ayat NR; Qiao PL; Vaidya AM; Ma D; Aminoshariae A; Stojanov I; Lu ZR
    Mol Imaging Biol; 2020 Dec; 22(6):1532-1542. PubMed ID: 32789648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.
    Wegner CS; Hauge A; Gaustad JV; Andersen LMK; Simonsen TG; Galappathi K; Rofstad EK
    Acta Oncol; 2017 Dec; 56(12):1754-1762. PubMed ID: 28661213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.
    Li Y; Han Z; Roelle S; DeSanto A; Sabatelle R; Schur R; Lu ZR
    Mol Pharm; 2017 Nov; 14(11):3906-3915. PubMed ID: 28976766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive assessment and therapeutic monitoring of drug-resistant colorectal cancer by MR molecular imaging of extradomain-B fibronectin.
    Vaidya A; Ayat N; Buford M; Wang H; Shankardass A; Zhao Y; Gilmore H; Wang Z; Lu ZR
    Theranostics; 2020; 10(24):11127-11143. PubMed ID: 33042274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment.
    Han Z; Cheng H; Parvani JG; Zhou Z; Lu ZR
    Magn Reson Med; 2018 Jun; 79(6):3135-3143. PubMed ID: 29082597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel plectin/integrin-targeted bispecific molecular probe for magnetic resonance/near-infrared imaging of pancreatic cancer.
    Wang Q; Yan H; Jin Y; Wang Z; Huang W; Qiu J; Kang F; Wang K; Zhao X; Tian J
    Biomaterials; 2018 Nov; 183():173-184. PubMed ID: 30172243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
    Bowman AW; Bolan CW
    Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pancreatic tumor development in KPC mice using multi-parametric MRI.
    Vohra R; Park J; Wang YN; Gravelle K; Whang S; Hwang JH; Lee D
    Cancer Imaging; 2018 Nov; 18(1):41. PubMed ID: 30409175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging biomarkers for pulsed focused ultrasound treatment of pancreatic ductal adenocarcinoma.
    Maloney E; Wang YN; Vohra R; Son H; Whang S; Khokhlova T; Park J; Gravelle K; Totten S; Hwang JH; Lee D
    World J Gastroenterol; 2020 Mar; 26(9):904-917. PubMed ID: 32206002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BIRC5 is a target for molecular imaging and detection of human pancreatic cancer.
    Liu SH; Hong Y; Markowiak S; Sanchez R; Creeden J; Nemunaitis J; Kalinoski A; Willey J; Erhardt P; Lee J; van Dam M; Brunicardi FC
    Cancer Lett; 2019 Aug; 457():10-19. PubMed ID: 31059751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenocarcinoma.
    Yamamoto K; Brender JR; Seki T; Kishimoto S; Oshima N; Choudhuri R; Adler SS; Jagoda EM; Saito K; Devasahayam N; Choyke PL; Mitchell JB; Krishna MC
    Cancer Res; 2020 Jun; 80(11):2087-2093. PubMed ID: 32245793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI of breast tumor initiating cells using the extra domain-B of fibronectin targeting nanoparticles.
    Sun Y; Kim HS; Park J; Li M; Tian L; Choi Y; Choi BI; Jon S; Moon WK
    Theranostics; 2014; 4(8):845-57. PubMed ID: 24955145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Molecular Imaging of Extradomain B Fibronectin Improves Imaging of Pancreatic Cancer Tumor Xenografts.
    Qiao P; Ayat NR; Vaidya A; Gao S; Sun W; Chou S; Han Z; Gilmore H; Winter JM; Lu ZR
    Front Oncol; 2020; 10():586727. PubMed ID: 33194740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
    Lu ZR; Laney V; Li Y
    Acc Chem Res; 2022 Oct; 55(19):2833-2847. PubMed ID: 36121350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical magnetic multimodality imaging of plectin-1-targeted imaging agent for the precise detection of orthotopic pancreatic ductal adenocarcinoma in mice.
    Zhang W; Liang X; Zhu L; Zhang X; Jin Z; Du Y; Tian J; Xue H
    EBioMedicine; 2022 Jun; 80():104040. PubMed ID: 35525203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
    Jia H; Li J; Huang W; Lin G
    BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens.
    Ma C; Yang P; Li J; Bian Y; Wang L; Lu J
    Abdom Radiol (NY); 2020 Mar; 45(3):782-788. PubMed ID: 31292672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.